The proposed legislation, known as the Ensuring Reproductive Freedom by Shielding Our Providers Act, allows prescribers to request that the prescription label for certain pharmaceuticals, specifically mifepristone, misoprostol, or their generic alternatives, display the name of the prescriber's health care practice instead of the prescriber's personal name. This change aims to enhance the privacy and safety of healthcare providers by reducing the potential for harassment or intimidation related to their prescribing practices. Dispensers and pharmacies are required to comply with this request if made by the prescriber.

The bill includes definitions for key terms such as "Dispenser," "Pharmacy," and "Prescriber," clarifying the roles of those involved in the dispensing of these medications. The act is set to take effect 30 days after its passage, promoting a more secure environment for healthcare providers while ensuring that patients still receive their prescribed medications.